The purpose of this study is to describe the safety and tolerability of two dose levels of OTO-201, placebo and sham when administered intra-operatively in pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
83
Call/Email Otonomy Central Contact for Trial Locations
San Diego, California, United States
Safety
Evaluation of adverse events, otoscopic exams, audiometry, and tympanometry
Time frame: Up to 1 month
Clinical Activity
Evaluation of physician reported and caregiver reported otorrhea
Time frame: Up to 1 month
Microbiological Eradication
Microbiological eradication of pretherapy bacteria
Time frame: Up to 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.